Citation Impact
Citing Papers
Heme oxygenase-1 affords protection against noncerebral forms of severe malaria
2009
Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities
2008
Transcriptional Regulation by Nrf2
2017 Standout
Heme Oxygenase-1 Inhibits the Expression of Adhesion Molecules Associated with Endothelial Cell Activation via Inhibition of NF-κB RelA Phosphorylation at Serine 276
2007
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
2002
Localized cell stimulation by nitric oxide using a photoactive porous coordination polymer platform
2013 StandoutNobel
Photoactivatable CO release from engineered protein crystals to modulate NF-κB activation
2016 StandoutNobel
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Heme Oxygenase-1 in Tumor Biology and Therapy
2010
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Biliverdin administration protects against endotoxin-induced acute lung injury in rats
2005
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation
2015
Heme oxygenase-1: from biology to therapeutic potential
2009
Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
2011 StandoutNobel
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Cancer Statistics, 2006
2006 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin
2009
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation
2007
Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates
2001
Pharmacological and Clinical Aspects of Heme Oxygenase
2008
Immunoregulatory effects of HO-1: how does it work?
2009
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Structurally Mapping Endogenous Heme in the CcmCDE Membrane Complex for Cytochrome c Biogenesis
2018 StandoutNobel
Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy
2005
Inhaled Carbon Monoxide Prevents Graft-Induced Intimal Hyperplasia in Swine
2006
A central role for free heme in the pathogenesis of severe malaria: the missing link?
2008
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Heme oxygenase-1 is not required for mouse regulatory T cell development and function
2006
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Induction of Carbon Monoxide in Donor Animals Prior to Organ Procurement Reduces Graft Immunogenicity and Inhibits Chronic Allograft Dysfunction
2006
Acute kidney injury
2021 Standout
Photoactive metal carbonyl complexes as potential agents for targeted CO delivery
2013
Carboxypeptidase G2-based gene-directed enzyme–prodrug therapy: a new weapon in the GDEPT armoury
2007
Regulatory T cells: how do they suppress immune responses?
2009 StandoutNobel
Light-triggered carbon monoxide delivery with Al-MCM-41-based nanoparticles bearing a designed manganese carbonyl complex
2014
Protective effect of carbon monoxide in transplantation
2006
Human heme oxygenase‐1 deficiency: A lesson on serendipity in the discovery of the novel disease
2007
Bilirubin and the risk of common non-hepatic diseases
2005
Bilirubin Can Induce Tolerance to Islet Allografts
2005
Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties
2004
Oxidative Stress in Cancer
2020 Standout
Statin‐mediated cytoprotection of human vascular endothelial cells: a role for Kruppel‐like factor 2‐dependent induction of heme oxygenase‐1
2007
The anti-mutagenic properties of bile pigments
2007
Hydrogen sulphide and its therapeutic potential
2007 Standout
Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia
2009
Biliverdin Therapy Protects Rat Livers From Ischemia and Reperfusion Injury
2004
Tumor-activated Prodrugs—A New Approach to Cancer Therapy
2004
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes
2014
Ex Vivo Application of Carbon Monoxide in University of Wisconsin Solution to Prevent Intestinal Cold Ischemia/Reperfusion Injury
2006
Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting
2001 StandoutNobel
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria
2007
The therapeutic potential of carbon monoxide
2010 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide
2006
Therapeutic Applications of Bilirubin and Biliverdin in Transplantation
2007
Heme Oxygenase-1 in Tumors: Is It a False Friend?
2007
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Heme oxygenase-1: A provenance for cytoprotective pathways in the kidney and other tissues
2006
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Heme Oxygenases in Cardiovascular Health and Disease
2016
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
2000
Preparation of a Cross-Linked Porous Protein Crystal Containing Ru Carbonyl Complexes as a CO-Releasing Extracellular Scaffold
2014 StandoutNobel
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
2010
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
2013
Heme oxygenase‐1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells
2007
Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome Proliferator-Activated Receptors
2007
Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence
2009
The coordinated increased expression of biliverdin reductase and heme oxygenase‐2 promotes cardiomyocyte survival: a reductase‐based peptide counters β‐adrenergic receptor ligand‐mediated cardiac dysfunction
2010
Heme Oxygenase-1
2006
HO-1 and CO Decrease Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Migration Via Inhibition of Nox1
2009
Light responsive metal–organic frameworks as controllable CO-releasing cell culture substrates
2016 StandoutNobel
Systemic Expression of Heme Oxygenase-1 Ameliorates Type 1 Diabetes in NOD Mice
2007
CO AS A CELLULAR SIGNALING MOLECULE
2005
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Sustained Tumor Regression of Human Colorectal Cancer Xenografts Using a Multifunctional Mannosylated Fusion Protein in Antibody-Directed Enzyme Prodrug Therapy
2005
Antibody–Enzyme Fusion Proteins for Cancer Therapy
2011
Coordination Modulation Method To Prepare New Metal–Organic Framework-Based CO-Releasing Materials
2018 StandoutNobel
Design of a CO-releasing Extracellular Scaffold Using in Vivo Protein Crystals
2014 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
The Relationship among Homocysteine, Bilirubin, and Diabetic Retinopathy
2011
Antibody-directed enzyme prodrug therapy (ADEPT): a review
1997
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Multiple event activation of a generic prodrug trigger by antibody catalysis
1999 StandoutNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of James McDaid being referenced
Preoperative radial artery volume flow is predictive of arteriovenous fistula outcomes
2016
Heme oxygenase‐1 is essential for and promotes tolerance to transplanted organs
2006
Bilirubin
2005
Heme oxygenase‐1 modulates the allo‐immune response by promoting activation‐induced cell death of T cells
2005
Donor Treatment With Carbon Monoxide Can Yield Islet Allograft Survival and Tolerance
2005
ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts.
1996
Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts
2004